x

Turning science into breakthroughs

Catalyzing the development of novel therapeutics and rapidly driving innovations toward clinical validation

Harvard University and Deerfield Management, a healthcare investment firm, have established a major strategic R&D alliance to speed the development and translation of biomedical and life-science innovations into transformative treatments that can improve life, health, and medical care.

Through a newly launched company called Lab1636, Deerfield has committed up to $100 million in initial funding to support the alliance. A private company wholly owned by affiliates of Deerfield, Lab1636 will support Harvard R&D projects throughout various stages of drug discovery and development, for example enabling studies to explicate the biology of disease, validate therapeutic targets, or achieve a proof-of-concept necessary for filing an Investigational New Drug (IND) application.

Harvard’s R&D projects to be funded by Lab1636 will be selected by a joint steering committee and the projects will be initiated by eligible principal investigators from labs across the University. The projects will generally focus on the development of novel therapeutics, ideally advancing many to a stage that would enable the filing of an IND application and, if successful, the commencement of clinical trials in patients.

Deerfield is a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.

Harvard’s Office of Technology Development (OTD) promotes the public good by fostering innovation and translating new inventions made at Harvard University into useful products that are available and beneficial to society. Our integrated approach to technology development comprises sponsored research and corporate alliances, intellectual property management, and technology commercialization through venture creation and licensing. For more information, please visit otd.harvard.edu.

Timeline for Proposal Submissions

Proposal Sourcing

Principal Investigators are invited to submit proposals.

Scientific Review

Your proposal will be reviewed by members of our scientific team.

Full Proposal

If your idea is selected for further evaluation, you will be invited to submit a full proposal.

Investment Evaluated

Your proposal will be carefully evaluated for funding by Deerfield’s investment team.

For more information on proposal submissions, please reach out to Lab1636 Scientific Collaboration Director Jonathan Kwan at jonathan_kwan@harvard.edu.

Have more specific questions?

Find answers to commonly asked questions or submit a specific request.